Mr. Inas Said reports

RISE NANO OPTICS ANNOUNCES ESTABLISHMENT OF NEW SPECTRAGUARD NANOMATERIAL PRODUCTION FACILITY IN ISRAEL

Rise Nano Optics Ltd. has established a new nanomaterial production facility within Sagam Optical Products Ltd.'s facilities in Israel dedicated to manufacturing the company's proprietary nanomaterial used in its SpectraGuard lens technology.

The new Rise-operated facility represents a significant expansion and advancement of the company's existing nanomaterial manufacturing capabilities. Operational as of Nov. 1, 2026, the facility is expected to increase Rise's nanomaterial production capacity by approximately four times compared with its previous manufacturing facility, allowing production of nanomaterial for 80,000 lenses per month while providing expanded warehousing capabilities and a more streamlined infrastructure for fulfilling nanomaterial orders to Rise's optical laboratory partners around the world.

The company's proprietary SpectraGuard technology is a patented nanoparticle optical lens treatment designed to provide eye protection by filtering 100 per cent of ultraviolet (UV) light and up to 90 per cent of wavelengths between 400 and 600 nanometres, including blue light, while preserving natural visual clarity and colour perception.

SpectraGuard nanomaterial is produced by Rise and supplied to authorized optical laboratory partners globally, where it is incorporated into lenses using the company's proprietary production processes. As Rise expands its network of laboratory partners across multiple markets, increasing the scalability, efficiency and reliability of nanomaterial production and fulfilment is an important component of the company's commercialization strategy.

The new facility is expected to provide Rise with:

• Approximately four times the nanomaterial production capacity of the company's previous manufacturing facility, providing additional capacity to support higher commercial volumes and a growing network of laboratory partners;
• More advanced production infrastructure designed specifically to support the manufacture and scaling of Rise's proprietary nanomaterial;
• Expanded warehousing capabilities for nanomaterial, production inputs and related inventory;
• Streamlined global fulfilment capabilities, enabling Rise to more efficiently supply nanomaterial to authorized laboratory partners across multiple geographic markets.

Rise will operate the new facility and maintain control over the production of its proprietary nanomaterial. Locating the operation within Sagam's facilities allows Rise to expand its manufacturing footprint within an established optical-industry environment while developing dedicated production, inventory and fulfilment capabilities to support the continued commercialization of SpectraGuard. Sagam, the largest independent lab in Israel, serves optical practices and eye care professionals across Israel and operates its own manufacturing and coating facilities.

Erik Ritchie, chief commercial officer of Rise Nano Optics, commented: "Our commercialization model is designed around enabling established optical laboratories to bring SpectraGuard to their existing customers. As that network expands, our ability to reliably produce, inventory and deliver nanomaterial becomes increasingly important. This new facility is designed to give us the capacity and infrastructure to support significantly greater volume while creating a more efficient pathway from nanomaterial production to delivery to our lab partners around the world."

The new facility is part of Rise's broader strategy to establish the manufacturing, laboratory and distribution infrastructure necessary to support the commercialization of SpectraGuard across multiple geographic markets. By increasing upstream nanomaterial production capacity while continuing to expand its network of authorized optical laboratories, the company is developing infrastructure intended to support greater commercial scale without requiring Rise to establish finished-lens manufacturing operations in each market it enters.

About Rise Nano Optics Ltd.

Rise Nano Optics trades on the Canadian Securities Exchange under the ticker symbol EYE. Rise is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible-light wavelengths. Its patented SpectraGuard technology integrates nanomaterial innovation, ophthalmic research and scalable optical engineering to serve both clinical and consumer eyewear markets globally.

We seek Safe Harbor.